Pan-Cancer Analyses of the Tumor Microenvironment Reveal That Ubiquitin-Conjugating Enzyme E2C Might Be a Potential Immunotherapy Target
Increasing evidence indicated that the tumor microenvironment (TME) played a crucial role in cancer initiation and progression. Ubiquitin-conjugating enzyme E2C (UBE2C) was differentially expressed in many cancer types. However, the immunological and prognostic roles of UBE2C were unclear. Different...
Saved in:
Main Authors: | Guang-zhao Huang, Ze-qun Chen, Juan Wu, Ting-ru Shao, Chen Zou, Yi-long Ai, Xiao-zhi Lv |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2021/9250207 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Eupalinolide B inhibits periodontitis development by targeting ubiquitin conjugating enzyme UBE2D3
by: Wenhua Kuang, et al.
Published: (2025-01-01) -
Polarization of ILC2s in Peripheral Blood Might Contribute to Immunosuppressive Microenvironment in Patients with Gastric Cancer
by: Qingli Bie, et al.
Published: (2014-01-01) -
The ubiquitin-conjugating enzyme UBE2D maintains a youthful proteome and ensures protein quality control during aging by sustaining proteasome activity.
by: Liam C Hunt, et al.
Published: (2025-01-01) -
Ubiquitination Enzymes in Cancer, Cancer Immune Evasion, and Potential Therapeutic Opportunities
by: Aiman B. Awan, et al.
Published: (2025-01-01) -
Characteristics of Immunobiology in the Tumor Microenvironment- Development of Immunotherapies
by: Jian Song, et al.
Published: (2019-01-01)